[go: up one dir, main page]

PE20090620A1 - Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen - Google Patents

Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen

Info

Publication number
PE20090620A1
PE20090620A1 PE2008001405A PE2008001405A PE20090620A1 PE 20090620 A1 PE20090620 A1 PE 20090620A1 PE 2008001405 A PE2008001405 A PE 2008001405A PE 2008001405 A PE2008001405 A PE 2008001405A PE 20090620 A1 PE20090620 A1 PE 20090620A1
Authority
PE
Peru
Prior art keywords
methyl
tetrahidro
benzazepin
amine
preparation procedure
Prior art date
Application number
PE2008001405A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Jean-Paul Valaine
Nicole Villeneuve
Bertrand Goument
Pascal Caignard
Catherine Thollon
Stefano Chimenti
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39323822&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090620(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PE20090620A1 publication Critical patent/PE20090620A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINAS DE FORMULA (I) DONDE R1 ES H, CICLOALQUILO(C3-C7), BENCILO O ALQUILO(C1-C6); R2, R3, R4 Y R5 SON CADA UNO H, OH, METILO, ALCOXI(C1-C6), ENTRE OTROS; R6, R7, R8 Y R9 SON CADA UNO H, ALCOXI(C1-C6), ENTRE OTROS; X ES O, NH O CH2; m Y p SON CADA UNO 0 O 1; n ES 1 O 2. SON COMPUESTOS PREFERIDOS: N-{[3,4-DIMETOXIBICICLO[4.2.0]OCTA-1,3,5-TRIEN-7-IL]METIL}-3-(7,8-DIMETOXI-1,2,4,5-TETRAHIDRO-3H-3-BENZAZEPIN-3-IL)-N-METIL-3-OXOPROPAN-1-AMINA, N-[2-(5,6-DIMETOXI-2,3-DIHIDRO-1H-INDEN-2-IL)METIL]-3-(7,8-DIMETOXI-1,2,4,5-TETRAHIDRO-3H-3-BENZAZEPIN-3-IL)-3-OXOPROPAN-1-AMINA, N-{[3,4-DIMETOXIBICICLO[4.2.0]OCTA-1,3,5-TRIEN-7-IL]METIL}-3-(7,8-DIMETOXI-1,2,4,5-TETRAHIDRO-3H-3-BENZAZEPIN-3-IL)-N-METIL-4-OXOBUTAN-1-AMINA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS BLOQUEAN LOS CANALES HCN (CANALES ACTIVADOS POR HIPERPOLARIZACION DEPENDIENTES DE NUCLEOTIDOS CICLICOS) SIENDO UTILES EN EL TRATAMIENTO DE CARDIOPATIA ISQUEMICA, INSUFICIENCIA CARDIACA, INFARTO DE MIOCARDIO
PE2008001405A 2007-09-11 2008-08-19 Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen PE20090620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706346A FR2920773B1 (fr) 2007-09-11 2007-09-11 Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PE20090620A1 true PE20090620A1 (es) 2009-05-30

Family

ID=39323822

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001405A PE20090620A1 (es) 2007-09-11 2008-08-19 Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen

Country Status (44)

Country Link
US (1) US8076325B2 (es)
EP (1) EP2036892B1 (es)
JP (1) JP4932805B2 (es)
KR (1) KR101078076B1 (es)
CN (1) CN101386594B (es)
AP (1) AP2384A (es)
AR (1) AR068386A1 (es)
AT (1) ATE460401T1 (es)
AU (1) AU2008207585B2 (es)
BR (1) BRPI0804091B8 (es)
CA (1) CA2639349C (es)
CL (1) CL2008002654A1 (es)
CO (1) CO6020016A1 (es)
CR (1) CR10229A (es)
CU (1) CU23706B7 (es)
CY (1) CY1110034T1 (es)
DE (1) DE602008000786D1 (es)
DK (1) DK2036892T3 (es)
EA (1) EA014756B1 (es)
EC (1) ECSP088731A (es)
ES (1) ES2342511T3 (es)
FR (1) FR2920773B1 (es)
HN (1) HN2008001393A (es)
HR (1) HRP20100259T1 (es)
JO (1) JO2652B1 (es)
MA (1) MA30315B1 (es)
ME (1) ME00981B (es)
MX (1) MX2008011164A (es)
MY (1) MY143079A (es)
NI (1) NI200800247A (es)
NZ (1) NZ571143A (es)
PA (1) PA8795301A1 (es)
PE (1) PE20090620A1 (es)
PL (1) PL2036892T3 (es)
PT (1) PT2036892E (es)
RS (1) RS51305B (es)
SA (1) SA08290567B1 (es)
SG (1) SG151172A1 (es)
SI (1) SI2036892T1 (es)
TW (1) TWI374029B (es)
UA (1) UA100003C2 (es)
UY (1) UY31305A1 (es)
WO (1) WO2009066041A2 (es)
ZA (1) ZA200807586B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
US9333208B2 (en) 2013-07-16 2016-05-10 Movses H. Karakossian HCN inhibitors affecting ganglion cell function and visual function
FR3020810B1 (fr) * 2014-05-06 2016-05-06 Servier Lab Nouveau sel de l'ivabradine et son procede de preparation.
AU2016374441B2 (en) 2015-12-17 2021-10-21 Eisai R&D Management Co., Ltd. Therapeutic agent for breast cancer
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20230140818A1 (en) * 2017-04-27 2023-05-04 The University Of Hong Kong Use of hcn inhibitors for treatment of cancer
CN112724001B (zh) * 2019-10-28 2022-12-13 鲁南制药集团股份有限公司 一种伊伐布雷定手性中间体化合物
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
CN117715902A (zh) * 2021-08-31 2024-03-15 卫材R&D管理有限公司 单环吡啶衍生物的制造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
JPH02193971A (ja) * 1989-01-20 1990-07-31 Yamanouchi Pharmaceut Co Ltd トリ置換―２，３，４，５―テトラヒドロベンズアゼピン誘導体とその中間体
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
AU6971894A (en) * 1993-05-27 1994-12-20 Smithkline Beecham Laboratoires Pharmaceutiques Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US6514964B1 (en) * 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CU23706B7 (es) 2011-10-05
AR068386A1 (es) 2009-11-11
WO2009066041A2 (fr) 2009-05-28
CU20080165A7 (es) 2011-03-21
JP4932805B2 (ja) 2012-05-16
ME00981B (me) 2012-06-20
ECSP088731A (es) 2008-10-31
ES2342511T3 (es) 2010-07-07
US8076325B2 (en) 2011-12-13
TW200918076A (en) 2009-05-01
CA2639349A1 (fr) 2009-03-11
EP2036892B1 (fr) 2010-03-10
EA014756B1 (ru) 2011-02-28
MY143079A (en) 2011-02-28
TWI374029B (en) 2012-10-11
PT2036892E (pt) 2010-05-10
EA200801828A3 (ru) 2009-08-28
CL2008002654A1 (es) 2009-03-20
SG151172A1 (en) 2009-04-30
BRPI0804091B1 (pt) 2020-09-29
RS51305B (sr) 2010-12-31
PL2036892T3 (pl) 2010-08-31
DK2036892T3 (da) 2010-06-07
AU2008207585A1 (en) 2009-03-26
JP2009108032A (ja) 2009-05-21
ATE460401T1 (de) 2010-03-15
CY1110034T1 (el) 2015-01-14
NI200800247A (es) 2011-01-10
JO2652B1 (en) 2012-06-17
FR2920773B1 (fr) 2009-10-23
BRPI0804091A2 (pt) 2009-05-05
PA8795301A1 (es) 2009-04-23
DE602008000786D1 (de) 2010-04-22
CN101386594A (zh) 2009-03-18
AP2384A (en) 2012-03-21
NZ571143A (en) 2010-04-30
KR101078076B1 (ko) 2011-10-28
HN2008001393A (es) 2011-05-11
BRPI0804091B8 (pt) 2021-05-25
EA200801828A2 (ru) 2009-04-28
SI2036892T1 (sl) 2010-06-30
HRP20100259T1 (hr) 2010-06-30
ZA200807586B (en) 2011-04-28
EP2036892A1 (fr) 2009-03-18
CR10229A (es) 2008-11-26
WO2009066041A3 (fr) 2009-12-17
HK1129667A1 (en) 2009-12-04
MA30315B1 (fr) 2009-04-01
AU2008207585B2 (en) 2013-08-22
AP2008004589A0 (en) 2008-08-31
CN101386594B (zh) 2012-05-16
KR20090027164A (ko) 2009-03-16
CO6020016A1 (es) 2009-03-31
SA08290567B1 (ar) 2011-06-22
MX2008011164A (es) 2009-03-10
FR2920773A1 (fr) 2009-03-13
CA2639349C (fr) 2011-03-22
US20090069296A1 (en) 2009-03-12
UA100003C2 (ru) 2012-11-12
UY31305A1 (es) 2008-10-31

Similar Documents

Publication Publication Date Title
PE20090620A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
NO20090760L (no) Nye tricykliske spiropiperidinforbindelser, deres synteser og deres anvendelser som modulatorer av kemokinreseptor-aktivitet
NO20063469L (no) Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister
AR078542A1 (es) Moduladores de gpr40 de pirrolidina
PE20120635A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20071245A1 (es) COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs)
PE20090641A1 (es) Amidas heterociclicas
PE20070115A1 (es) Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
EA201171333A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-с-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
PE20090042A1 (es) Analogos de ciclopamina
PE20080418A1 (es) Compuestos y composiciones como moduladores de la via de hedgehog
PE20080409A1 (es) Compuestos que modulan en el receptor cb2
PE20070011A1 (es) Formulaciones farmaceuticas de compuestos inhibidores de proteasa del vhc o catepsina
PE20090890A1 (es) Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c
PE20070217A1 (es) Derivados de isoquinolona sustituidos con piperidinilo
PE20141075A1 (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
PE20130311A1 (es) Composiciones y metodos para modular la via de senalizacion de wnt
DE602005008558D1 (de) Kondensierte heterocyclische verbindungen und deren verwendung als antagonisten des metabotropen reznkungen
PE20060186A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion asi como su uso como medicamento
PE20080889A1 (es) Aminometil-4-imidazoles
PE20140610A1 (es) Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina

Legal Events

Date Code Title Description
FG Grant, registration